A computational approach to analyze the missense mutations in human angiogenin variants leading to amyotrophic lateral sclerosis
DOI:
https://doi.org/10.3329/bjp.v8i4.15259Keywords:
Amyotrophic lateral sclerosis, Angiogenin, Flexibility, Free energy, Missense mutation, Protein dockingAbstract
The most detrimental missense mutations of angiogenin causing Amyotrophic lateral sclerosis were identified computationally and the substrate binding efficiencies of these mutations were also analyzed. Out of 12 variants, I-Mutant 2.0, SIFT and PolyPhen programs identified 3 variants that were less stable, deleterious and damaging respectively. Modeling of these 3 variants was performed to understand the change in their conformations with respect to the native angiogenin by computing their RMSD and Total energy. The native and the 3 mutants were docked with ribonuclease inhibitor to explain the binding efficiencies of those detrimental missense mutations. The loss of binding affinity with their interacting protein namely ribonuclease inhibitor was investigated by computing the flexibility of binding amino acids of angiogenin and computing the binding free energy (ΔG) between native and mutant complexes.
Downloads
277
124 Read
2
References
Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006; 442: 916-19.
Bava KA, Gromiha MM, Uedaira H, Kitajima K, Sarai A. ProTherm, version 4.0: Thermodynamic database for proteins and mutants. Nucleic Acids Res. 2004; 32: 120-21.
Bento-Abreu A, Van Damme P, Van Den Bosch L, Robberecht W. The neurobiology of amyotrophic lateral sclerosis. Eur J Neurosci. 2010; 31: 2247-65.
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein Data Bank. Nucleic Acids Res. 2000; 28: 235-42.
Boeckmann B, Bairoch A, Apweiler R, Blatter MC, Estreicher A, Gasteiger E, Martin MJ, Michoud K, O'Donovan C, Phan I, Pilbout S, Schneider M. The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res. 2003; 31: 365-70s.
Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci. 2004; 27: 723-49.
Capriotti E, Fariselli P, Casadio R. I-Mutant2.0: Predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res. 2005; 33: 306-10.
Capriotti E, Fariselli P, Rossi I. A three-state prediction of single point mutations on protein stability changes, BMC Bioinformatics. 2008; 26: 56-59.
Carlson HA, McCammon JA. Accommodating protein flexibility in computational drug design. Mol Pharmacol. 2000; 57: 213-18.
Cavallo A, Martin AC. Mapping SNPs to protein sequence and structure data. Bioinformatics. 2005; 21: 1443-50.
DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011; 72: 245-56.
Delarue M, Dumas P. On the use of low-frequency normal modes to enforce collective movements in refining macromolecular structural models. Proc Natl Acad Sci USA. 2004; 101: 6957-62.
Dion PA, Daoud H, Rouleau GA. Genetics of motor neuron disorders: New insights into pathogenic mechanisms. Nat Rev Genet. 2009; 10: 769-82.
Greenway MJ, Alexander MD, Ennis S, Traynor BJ, Corr B, Frost E, Green A, Hardiman O. A novel candidate region for ALS on chromosome 14q11.2. Neurology 2004; 63: 1936-38.
Han JH, Kerrison N, Chothia C, Teichmann SA. Divergence of interdomain geometry in two-domain proteins. Structure 2006; 14: 935-45.
Hallahan TW, Shapiro R, Vallee BL. Dual site model for the organogenic activity of angiogenin. Proc Natl Acad Sci USA. 1991; 88: 2222-26.
Hallahan TW, Shapiro R, Strydom DJ, Vallee BL. Importance of asparagine-61 and asparagine-109 to the angiogenic activity of human angiogenin. Biochemistry 1992; 31: 8022-29.
Hinkle A, Tobacman LS. Folding and function of the troponin tail domain, effects of cardiomyopathic troponin T mutations. J Biol Chem. 2003; 278: 506-13.
Ivan A. Adzhubei, Steffen S, Leonid P. A method and server for predicting damaging missense mutations. Nat Methods. 2010; 7: 248-49.
Kieran D, Sebastia J, Greenway MJ, King MA, Connaughton D, Concannon CG, Fenner B, Hardiman O, Prehn JH. Control of motoneuron survival by angiogenin. J Neurosci. 2008; 28: 14056-61.
Kishikawa H, Wu D, Hu GF. Targeting angiogenin in therapy of amyotropic lateral sclerosis. Expert Opin Ther Targets. 2008; 12: 1229-42.
Kobe B, Deisenhofer J. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease. Am J Mol Biol. 1996; 264: 1028-43.
Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009; 4: 1073-81.
Lindahl E, Azuara C, Koehl P, Delarue M. NOMAD-Ref: visualization, deformation and refinement of macromolecular structures based on all-atom normal mode analysis. Nucleic acids Res. 2006; 34: 52-56.
Moroianu J, Riordan JF. Identification of the nucleolar targeting signal of human angiogenin. Biochem Biophys Res Commun. 1994; 203: 1765-72.
Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003; 31: 3812-14.
Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 2001; 11: 863-74.
Padhi AK, Kumar H, Vasaikar SV, Jayaram B, Gomes J. Mechanisms of loss of functions of human angiogenin variants implicated in amyotrophic lateral sclerosis. PLoS ONE. 2012; 7: e32479.
Parthasarathy S, Murthy MR. Protein thermal stability: Insights from atomic displacement parameters (B values). Protein Eng. 2000; 13: 9-13.
Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: Server and survey. Nucleic Acids Res. 2002; 30: 3894-900.
Renton AE, Majounie E, Waite A. Simo´n-Sa´nchez J, Rollinson S, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011; 72: 257-68.
Ringe D, Petsko GA. Study of protein dynamics by X-ray diffraction. Methods Enzymol. 1986; 131: 389-433.
Shapiro R. Cytoplasmic ribonuclease inhibitor. Meth Enzymol. 2001; 341: 611-28.
Shapiro R, Riordan JF, Vallee BL. Characteristic ribonucleolytic activity of human angiogenin. Biochemistry 1986; 25: 3527-32.
Sharma S, Ding F, Nie H, Watson D, Unnithan A, Lopp J, Pozefsky D, Dokholyan NV. iFold: A platform for interactive folding simulation of proteins. Bioinformatics. 2006; 22: 2693-94.
Subramanian V, Crabtree B, Acharya KR. Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons. Hum Mol Genet. 2008; 17: 130-49.
Suhre K, Sanejouand YH. ElNe´mo: A normal mode webserver for protein movement analysis and the generation of templates for molecular replacement. Nucleic Acids Res. 2004; 32: 610-14.
Tina KG, Bhadra R, Srinivasan N. PIC: Protein interactions calculator. Nucleic Acids Res. 2007; 35: 473-76.
Tovchigrechko A, Vakser IA. GRAMM-X public web server for protein-protein docking. Nucleic Acids Res. 2006; 34: 310-14.
Vande Velde C, Dion PA, Rouleau GA. Amyotrophic lateral sclerosis: New genes, new models, and new mechanisms. F1000 Biol Rep. 2011; 3: 18.
Varfolomeev SD, Uporov IV, Fedorov EV. Bioinformatics and molecular modeling in chemical enzymology: Active sites of hydrolases. Biochemistry (Mosc). 2002; 67: 1099-108.
Wu D, Yu W, Kishikawa H, Folkerth RD, Iafrate AJ, Shen Y, Xin W, Sims K, Hu GF. Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Ann Neurol. 2007; 62: 609-17.
Yip YL, Famiglietti M, Gos A, Duek PD, David FP, Gateau A, Bairoch A. Annotating single amino acid polymorphisms in the UniProt/Swiss-Prot knowledge base. Hum Mutat. 2008; 29: 361-66.
Yip YL, Scheib H, Diemand AV, Gattiker A, Famiglietti LM, Gasteiger E, Bairoch A. The Swiss-Prot variant page and the ModSNP database: A resource for sequence and structure information on human protein variants. Hum Mutat. 2004; 23: 464-70.
Yuan Z, Bailey TL, Teasdale RD. Prediction of protein B-factor profiles. Proteins 2005; 58: 905-12.
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
